|
Recent Newsletters
FDA approves inclisiran | COVID-19 vaccines & myocarditis/myopericarditis | Looking ahead to 2022 |
Economics & Policy: Cardiologist salaries | Medical malpractice lawsuits | Medicare spending on cardiology drops |
Heart Failure: The optimal HFrEF treatment | KCCQ-12 scores & acute HF |
An industry first for Philips | FDA approves rivaroxaban for treating, preventing blood clots in children |
Vascular & Endovascular: J&J vaccine linked to blood clot risks | New PCI, CABG guidelines | TEVAR outcomes |
Cardiologist salaries up 2% as pandemic continues | Edwards gains a new FDA approval | DOACs & AFib |
Heart Rhythm: Ablation vs. drug therapy for AFib | ‘Surprising’ trends in ICD use among HCM patients |